International Conference on Neurology and Neuro-oncology
ICNNO
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest advancements in neuro-oncology, focusing on innovative therapies and treatment modalities for brain tumors. Participants will discuss the implications of these developments for clinical practice and patient outcomes.
SDG 3
SDG 4
This track will delve into the role of advanced neuroimaging techniques in the diagnosis and monitoring of brain tumors. Emphasis will be placed on the integration of imaging modalities to enhance diagnostic accuracy and treatment planning.
SDG 3
This session will focus on the identification and validation of tumor biomarkers in neuro-oncology. Discussions will center on their potential to guide therapeutic decisions and improve patient stratification.
SDG 3
SDG 9
This track will highlight cutting-edge surgical techniques and technologies in the management of brain tumors. Experts will share insights on minimally invasive approaches and their impact on patient recovery and outcomes.
SDG 3
SDG 4
This session will address the complexities associated with metastatic brain tumors, including diagnosis, treatment challenges, and patient management strategies. Participants will explore multidisciplinary approaches to improve care for affected patients.
SDG 3
SDG 10
This track will examine the design and implementation of clinical trials in neuro-oncology, focusing on innovative trial methodologies and patient recruitment strategies. Discussions will also cover regulatory considerations and ethical implications.
SDG 3
SDG 9
This session will review emerging therapeutic agents and combination therapies in the treatment of brain tumors. Participants will discuss the mechanisms of action and clinical efficacy of these novel approaches.
SDG 3
SDG 4
This track will explore the intersection of neuroscience research and clinical neuro-oncology, highlighting how basic science discoveries can inform clinical practice. Emphasis will be placed on translational research and its impact on patient care.
SDG 3
SDG 4
This session will focus on the importance of quality of life and supportive care for patients with brain tumors. Discussions will include psychosocial support, palliative care, and strategies to enhance patient well-being.
SDG 3
SDG 10
This track will address the ethical challenges faced in neuro-oncology research and clinical practice. Participants will engage in discussions on informed consent, patient autonomy, and the implications of emerging therapies.
SDG 3
SDG 16
This session will provide a global perspective on the future directions of neuro-oncology, including international collaborations and research initiatives. Participants will discuss the challenges and opportunities in advancing neuro-oncologic care worldwide.
SDG 3
SDG 17